Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk
- PMID:11592982
- PMCID: PMC60097
- DOI: 10.1073/pnas.221364198
Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk
Abstract
The Royal College of Surgeons (RCS) rat is a widely studied animal model of retinal degeneration in which the inability of the retinal pigment epithelium (RPE) to phagocytize shed photoreceptor outer segments leads to a progressive loss of rod and cone photoreceptors. We recently used positional cloning to demonstrate that the gene Mertk likely corresponds to the retinal dystrophy (rdy) locus of the RCS rat. In the present study, we sought to determine whether gene transfer of Mertk to a RCS rat retina would result in correction of the RPE phagocytosis defect and preservation of photoreceptors. We used subretinal injection of a recombinant replication-deficient adenovirus encoding rat Mertk to deliver the gene to the eyes of young RCS rats. Electrophysiological assessment of animals 30 days after injection revealed an increased sensitivity of treated eyes to low-intensity light. Histologic and ultrastructural assessment demonstrated substantial sparing of photoreceptors, preservation of outer segment structure, and correction of the RPE phagocytosis defect in areas surrounding the injection site. Our results provide definitive evidence that mutation of Mertk underlies the RCS retinal dystrophy phenotype, and that the phenotype can be corrected by treatment of juvenile animals. To our knowledge, this is the first demonstration of complementation of both a functional cellular defect (phagocytosis) and a photoreceptor degeneration by gene transfer to the RPE. These results, together with the recent discovery of MERTK mutations in individuals with retinitis pigmentosa, emphasize the importance of the RCS rat as a model for gene therapy of diseases that arise from RPE dysfunction.
Figures





Similar articles
- Mertk triggers uptake of photoreceptor outer segments during phagocytosis by cultured retinal pigment epithelial cells.Feng W, Yasumura D, Matthes MT, LaVail MM, Vollrath D.Feng W, et al.J Biol Chem. 2002 May 10;277(19):17016-22. doi: 10.1074/jbc.M107876200. Epub 2002 Feb 22.J Biol Chem. 2002.PMID:11861639
- AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa.Smith AJ, Schlichtenbrede FC, Tschernutter M, Bainbridge JW, Thrasher AJ, Ali RR.Smith AJ, et al.Mol Ther. 2003 Aug;8(2):188-95. doi: 10.1016/s1525-0016(03)00144-8.Mol Ther. 2003.PMID:12907141
- Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy.Tschernutter M, Schlichtenbrede FC, Howe S, Balaggan KS, Munro PM, Bainbridge JW, Thrasher AJ, Smith AJ, Ali RR.Tschernutter M, et al.Gene Ther. 2005 Apr;12(8):694-701. doi: 10.1038/sj.gt.3302460.Gene Ther. 2005.PMID:15660111
- A Comprehensive Review of Mutations in the MERTK Proto-Oncogene.Parinot C, Nandrot EF.Parinot C, et al.Adv Exp Med Biol. 2016;854:259-65. doi: 10.1007/978-3-319-17121-0_35.Adv Exp Med Biol. 2016.PMID:26427420Review.
- Prospects for gene therapy.Ali RR.Ali RR.Novartis Found Symp. 2004;255:165-72; discussion 173-8.Novartis Found Symp. 2004.PMID:14750603Review.
Cited by
- Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats.Deng WT, Dinculescu A, Li Q, Boye SL, Li J, Gorbatyuk MS, Pang J, Chiodo VA, Matthes MT, Yasumura D, Liu L, Alkuraya FS, Zhang K, Vollrath D, LaVail MM, Hauswirth WW.Deng WT, et al.Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831.Invest Ophthalmol Vis Sci. 2012.PMID:22408006Free PMC article.
- Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein.Gibbs D, Kitamoto J, Williams DS.Gibbs D, et al.Proc Natl Acad Sci U S A. 2003 May 27;100(11):6481-6. doi: 10.1073/pnas.1130432100. Epub 2003 May 12.Proc Natl Acad Sci U S A. 2003.PMID:12743369Free PMC article.
- Gene Therapy in Retinal Dystrophies.Ziccardi L, Cordeddu V, Gaddini L, Matteucci A, Parravano M, Malchiodi-Albedi F, Varano M.Ziccardi L, et al.Int J Mol Sci. 2019 Nov 14;20(22):5722. doi: 10.3390/ijms20225722.Int J Mol Sci. 2019.PMID:31739639Free PMC article.Review.
- Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives.Garafalo AV, Cideciyan AV, Héon E, Sheplock R, Pearson A, WeiYang Yu C, Sumaroka A, Aguirre GD, Jacobson SG.Garafalo AV, et al.Prog Retin Eye Res. 2020 Jul;77:100827. doi: 10.1016/j.preteyeres.2019.100827. Epub 2019 Dec 30.Prog Retin Eye Res. 2020.PMID:31899291Free PMC article.Review.
- MERTK-Mediated LC3-Associated Phagocytosis (LAP) of Apoptotic Substrates in Blood-Separated Tissues: Retina, Testis, Ovarian Follicles.Yefimova MG, Ravel C, Rolland AD, Bourmeyster N, Jégou B.Yefimova MG, et al.Cells. 2021 Jun 9;10(6):1443. doi: 10.3390/cells10061443.Cells. 2021.PMID:34207717Free PMC article.Review.
References
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous